William G. Herrick

Sorafenib resistance and JNK signaling in carcinoma during extracellular matrix stiffening

Thuy V. Nguyen, Marianne Sleiman, Timothy Moriarty et al. · Biomaterials · 2014 · 148 citations · Full text

Medicine, Cancer Biology, Oncology +14

PEG-Phosphorylcholine Hydrogels As Tunable and Versatile Platforms for Mechanobiology

William G. Herrick, Thuy V. Nguyen, Marianne Sleiman et al. · Biomacromolecules · 2013 · 69 citations · Full text

Natural Sciences, Bioengineering, Biomedical Engineering +17

Redox phospholipidomics discovers pro-ferroptotic death signals in A375 melanoma cells in vitro and in vivo

Yulia Y. Tyurina, Alexandr A. Kapralov, Vladimir A. Tyurin et al. · Redox Biology · 2023 · 47 citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial

Andrea M. Gross, Geraldine O’Sullivan Coyne, Eva Dombi et al. · Nature Medicine · 2025 · 38 citations · Full text

Medicine, Neurology, Oncology +8

Phase II trial of the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886 Hydrogen Sulfate) in adults with neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas (PN).

Geraldine O’Sullivan Coyne, Andrea M. Gross, Eva Dombi et al. · Journal of Clinical Oncology · 2020 · 24 citations

Medicine, Neurology, Pharmacology +15